Literature DB >> 14499192

Characterization of transdermal solute transport induced by low-frequency ultrasound in the hairless rat skin.

Mizue Mutoh1, Hideo Ueda, Yasushi Nakamura, Kotaro Hirayama, Mahito Atobe, Daisuke Kobayashi, Yasunori Morimoto.   

Abstract

Sonophoretic drug transport with low-frequency (41-445 kHz) and low-intensity (60-240 mW/cm2) ultrasound was characterized using hydrophilic calcein and deuterium oxide (D2O) as a solvent vehicle in excised hairless rat skin. The excised skin was mounted in vertical diffusion chambers for measurement of skin resistance and sonophoretic transport of calcein and D2O. The calcein content of the skin was also measured after ultrasound application. When the stratum corneum (sc) side was exposed to ultrasound at an intensity of 60 mW/cm2 for 30 min, the calcein flux in the sc-to-dermis direction was increased by 22.3-, 6.3-, and 3.8-fold from a baseline of 0.0088+/-0.0100 nmol/(cm2 x h) at frequencies of 41, 158, and 445 kHz, respectively, without significant changes in skin resistance. The ultrasonically-enhanced fluxes returned to baseline following cessation of the ultrasound application. At 41 kHz, there was a further increase in the magnitude of enhancement and a significant decrease in skin resistance (by 50% of the baseline resistance) on increasing the intensity from 60 to 120 mW/cm2, whereas no further enhancement was observed at 158 and 445 kHz up to 240 mW/cm2. Comparison of the calcein content in the skin before, during, and after ultrasound application at 41 kHz, 120 mW/cm2, was consistent with a transient ultrasonically-induced increase in calcein flux. In the sonophoretic transport experiments at 41 kHz, 120 mW/cm2, calcein transport correlated well with D2O transport. When 41-kHz ultrasound was applied to the sc side at 120 mW/cm2, the calcein and D2O fluxes in the sc-to-dermis direction were 13.7- and 5.2-fold higher than those in the dermis-to-sc direction. Similar directionality was also observed in tape-stripped skin, suggesting possible induction of convection in the direction of sound propagation. However, dermal application under the same ultrasound conditions induced neither an increase in calcein and D2O transport nor a decrease in skin resistance. These results demonstrate that low frequency sonophoresis is a potentially useful technique for controlling transdermal drug transport. Convective solvent flow as well as structural alteration of the skin induced by ultrasound are likely to be responsible for the observed sonophoretic transport enhancement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499192     DOI: 10.1016/s0168-3659(03)00306-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Fetal membrane transport enhancement using ultrasound for drug delivery and noninvasive detection.

Authors:  Lior Wolloch; Aharon Azagury; Riki Goldbart; Tamar Traitel; Gabriel Groisman; Mordechai Hallak; Joseph Kost
Journal:  Pharm Res       Date:  2014-07-31       Impact factor: 4.200

Review 2.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

3.  Microneedle-Assisted Percutaneous Delivery of a Tetramethylpyrazine-Loaded Microemulsion.

Authors:  Qiang Zu; Yanyan Yu; Xiaolin Bi; Ren Zhang; Liuqing Di
Journal:  Molecules       Date:  2017-11-21       Impact factor: 4.411

Review 4.  Bio-Functional Textiles: Combining Pharmaceutical Nanocarriers with Fibrous Materials for Innovative Dermatological Therapies.

Authors:  Daniele Massella; Monica Argenziano; Ada Ferri; Jinping Guan; Stéphane Giraud; Roberta Cavalli; Antonello A Barresi; Fabien Salaün
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

Review 5.  Perspectives on transdermal ultrasound mediated drug delivery.

Authors:  Nadine Barrie Smith
Journal:  Int J Nanomedicine       Date:  2007

6.  Electrically and Ultrasonically Enhanced Transdermal Delivery of Methotrexate.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Pharmaceutics       Date:  2018-08-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.